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Results: OP (~vents oocuffo~ m t 0 pts (4%); no pts wdh I SC h~d OP events, 
mfl0cling RVS m 9 pts Late CE o-~urrod m 30 pts, morn commonly w=th ISC 
An Eagle s~m ot 0 was present m 39 pt~, of whom 1 had OP (wont and 4 
(10%) I'~d I~to eve.~ts tSC was a predictor of late events after adlustmg for 
Eagle scorn, gende, ~nd LV dystunchon Scar was not a~so~at¢,d with CE 
Eddy eyelets Late events  ComOme~ 
P 0;~3 0000t 0~003 
Conct~ons. !SC ~ ~ is more p f~we el late than OP events E~gle 
~e m.qy be k~sS e f t~ for pred~ction of tale than OP-CE, SO DbE may be 
~.isek!! to~ p f ~  Of late CE in pls at low ctin~-ll risk tot OP events 
~ Exe l t ;=  ~ Have S imi la r  E f f i cacy  fo r  Cardiac 
: Dtpyddamole  SPEc'Ir, Dobu~m!ne Echo,  #!1¢1 
RISk ~ i f i~at !on  - Exl~rience in 494 Patients 
u~ng Amt~ Su~ 
D R~bm, R Ballot. T Ma~ck.  CP, b~etandChn~c, Ctevetanll~ OH. USA 
Compaltsons of ~n '1oN)  SPECT (DIP/) and (hdD~amme ~=,cho (ObE) for 
cerd~ac ask stratd~at~on (CRS) are d=fficu~t  to differences ~n patient m~x 
and refer!at pattern~ between cen~ers. We compared CRS in pl"s undergoing 
aortic anetm/sm repa,~ at a s~gte center where the cho~."e of lest ~s ctete~m,ned 
by avadabt~ty and phys~-~a~n preference 
A~thod~. P~ underwent [TOE, DI~. e~rerc~e test (ExT) or angiography 
(.tng~o) ac¢oro~J tocbn~cal|uclgme~ Peeoperatwe vents (OP) were defined 
~s card~: ~eath, [~arctzot't or presumed ~schem~c ever,~. 
Rebuffs Of 494 pts, 8~ had at least ore EaSe lacier, 347 (70%) had a 
stresstestand 11~(23%)ortdet'went an~ow~thoutstress OPeventsoccurred 
in 24 (49%) After exclus~3~ Of revasc, ulanzat~n (RVS). OP events occurred 
wife s=m~lar f equer~cy ~n p~ ur~ercj~ng Dpy, DbE. and E~T (p = NS) Rs 
having ang~o without stress were more likely to ut'~erge preoperat~e RVS 
(28% vs 3%. p < O.Ot ). Five events ~.-curred ~n 47 pts |11%) ~ abnormal 
stress tests and po~, ,e  ang~o who proceeded wrthout RVS. compared with 
no events ~n 8 pts w~th abno~nal stress test5 and RVS or nOn'hal ar~(os 
N Posse ~e~! PrE-~p RVS OP E~ 
85 22 I215%) 6 3 ~4%) 
D~E 110 a (7'=~t 2 4 (4=~;) 
E~T 152 33 (~o)  3 9 ;6%t 
Anglo 116 61 i53%) 33 7 ~8%) 
Cor~us[on CE occur ~n - 5% pts at ~ surgery Outcomes tollQwmg 
CRS w~th Dpy. DbE and ExT appear comparab~ despite fewer po'~mve DbE 
• Diagnostic and Features of Mult i  prognos.c 
Vessel Coronary Artery Disease by  Oobutamine  
St ress  Echocard iogrsphy  
T X~e. J Garza. S. Tavackoh. M Adams. M Abroad. Umvers~ty of Texas 
Afed~cal Branch. Galveston, TX. USA 
Four hundred and twenty five paber,ts (pts) with coronary a~gtograms w~thm 
3 months ot Dot~tamme stress echocarc~ography (DSE) were selected term 
2067 cortsecutwe DSE studies. S~xty-nme pts with prevrous MI and 120 pts 
~th revasculanZt~on were exclucfed. CAD was significant if I or more vessels 
had : 70% stenos[s. One hundred and eight pts w=thout sfgmficant CAD (group 
I), 47 pts with 1 vessel (group It). and 81 pts with multi ~,essel disease (group 
III). were tollowecl for cardiac events including unstable angina. ML cardiac 
arrhythmia. CHF. revasculanzatton and death for 155 : 11 2 months 
t II Ill p 
5111 II0 ~9:12  005 
72 3 85 4 
Resting LVEF (%) 52 7 : 108 
D~gnosbc 
Sens~tw=ty (%) 
Sl~otictty (%) 70 4 
FoUo'~-Up 
Event rate (%) t2 
(*) Predichve value 
DSE 6 25 
Multi WMA" 7 14 
298 358 OOt 
2.94 386 - 00t 
32 42 4 0 0 
"Multtsogment LV wall motion abnormality 
Patients with multi-vessel CAD have a significantly higher incidence of 
+re DSE with multi-segment LV WMA and have increased event rate dunng 
follow-up. 
-1~__152~ Dobutamlne St r ia  Echocar¢llography In E~. t /  
. . . . . . .  Patients; A Comparieon Botw~n Patients Over 
and Under the Ap  o! 70 Years 
T Xte, J G~r~,a M Khan, M Adam~, J Esqu~vel~Avlh~, M Ahn~d Universe, 
ot Texa~ Me~eal Br#n~h, Galveston, TX, USA 
Out of 2067 conseculwely performed dobu!amme ~lress e~hoc~rd~og~,ams 
(DOE), 144 patients (pts) were e~cl~kH:l d~ to limited =t~r  T~ ~U~ 
and thirty four pts, age ~ 70 vrs (mean age 75.4 -r 4 7) wflh ",09 males (48 6%) 
were comp~ff~l to !(~g pts with age .* 74 yrs (mean age ~ ? ¢ 99) w~lh ?t~ 
(455%) males. The peak dobutamme and atropine doses were Io~r  m age 
• 74grOUp32,1 ± 8.?mcg/kg/mm and041 ± 026mg,¢ompafedtOage ~70, 
349 ~ 7 5 mcg.'l*ohl,n, 4 51 ~ 027 mg (p ~ 005), and the % Of pts achieving 
larget heart rate was higher in age : 74 greup, 89.3 ~: 11 2 compared to age 
.70  group, 81 0 • t l  9 (p - 4 000t) The changes m double produ~ Item 
baseline to peak DSE were lower In <70, 395 ¢ 17.8% compared to ¢ 70, 
45 2 ~ 16.7% (p ~ 0.0001 ). All pt~ were followed for cardiac events =ncludmg 
unStabte ang!n~, MI, CHF, aWhylhm=as, revascutanzatmn and death In pts 
with positive !D~E for isehem*a, 29 Of 72 (40 3%) in : 70 group had events 
compared to t09 ot 405 (26 g%) m ~ 74 group (p ~ 40,5) over a totlow-up 
penod of 14.9 ~: t02  mo~fhs After adlustmg !or coronary nsk factors, LV 
dystunct~ofl, ' 3rona~ artery d~sease, prevto,Js revasculanzat=on, and ML a 
pos¢t~e OSE =n - 70 group had a t 6 told h~gher ask ot hJture cardiac events 
when compared to ~ 70 group (p ~ 441)  The ask ratios of a negative DSE 
were ~mltar m the two groups. The data rod!cote a h=gher ask of cardiac events 
~n patients w~th a positive DSE for mchem~a over the age of 70 years 
f 1152-1231 Increased Adverse Events in Patients on 
Calcium Champ,! Blocker Therapy and Positive 
Dobutamlne  Shl~sa Echor .a rd iogrsms 
T X~e, M Adams, J.G. Esqu~veI-Avda. M. Ahmad Unwersny of Texas Mectcat 
B~,  G~ve-~ton, TX. USA 
One thousand one hundred and eccJht pal]eats erlher on calcium channel 
blockers or on no cardiac mechcar ons dunng dobutamme stress echocarcho- 
cj~aphy (DSE) were selected front 2067 consecutwe DSE studies; 563 pts, 
mean age 55.5 ~: 118 yrS, 274 ~48%) males on calcium channel blockers 
(Group I) and 545 pts, mean age 53 8 ~ 126 yrs, 239 (43 9%) males, wllhout 
cardiac med~ca~ons (Group I1) None of lhe Group I pts were on p-blockers 
Oobutamrne dose. use of atrepme, resting heart rate and peak double producl 
were no[ O,ttere,,t between gr¢.-.ap~ The sensrlivrly and specff~ty for DSE in 
delectmg ~chem~a m 203 pts with drip.grams were 8 t ~= and 73 2% m group 
I and 78.3% ano ~0 6% ~n group It. All pt~ were followed for cardiac events 
mcfuchng unstable angina. MI. CHF. arrhythrmas revasculanzat~on and dealt', 
Fottow-up pP.nods were 16 7 ~ t0 8 and 15.4 ¢ 10 7 months for group I and 
It respectively Seventy-one ot 563 pts (126%) m group I had cardiac events 
compared to 40 ot 545 p~s (7 3%) ~n group II (p - 0.0005) Foflowmg adiust- 
meet for core, tory ns~ !dolors, LV dy~unchon coronary artery disease. MI and 
reva~culanza~n by Cox mu~hvanate re~jress~on analys~s, the nsk r'm~o f pts 
w~th posrt~ve DSE for future events m group I was 3.99 (p = 0.0001) compared 
to 2 13 (p - 0.05) in group II, 1 86 fold higher (p = 0.08). The data ~ndicate 
t~at DSE is eclua[~/sensitive in ~etectmg ~'hem~a, however, a positwe DSE 
=n pts on ~m~Rant  caloum channel blocker therapy was assocmted w~th a 
h~gher ask of future carchac events 
[ '1152-124  ! P rognost i c  Va lue o f  Dobutemine  L i Echocardiography Is Compromised in Patients 
With Atr ial  Rbr i l l a t ton  Despite Adequate Stress  
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Ohio. USA 
Interpretation of dobutamme echo (ObE) in pts wdh atnal fibnflat~on (AFt may 
De dzfficult because of companng cycles of va~ng RR ,ntetval We sought to 
document hemodynamlc profile, e~cacy and prognostic value of ObE in AF. 
Method.~: Of 301t censecuhve pts undergoing DbE over 5 years, 115 had 
AF at res t A stanclard Db protocol was usecl (5.-40 mc@'k~;mm ~n 3 mm 
=ncrements w=th atropine up to 2 mg). Endpomts were target heart rate (HR) 
.85% prc, dicted {PHR). maximum dose or dose hmdlng slde effects 
Results Pts ~,,~th AF were older (73 ± 8 v'S 65 ± 12 y. p - 00001 ). more 
hkely to be men (68¢0 vs. 56%. p - 0.4t). taking digoxm (64% vs 13%, p - 
0.0(301 ) and diuretic~ (51% vs, 3L~/o, p - 0.0001 ). AF had h~gher %PHR at rest 
(55 ± 10 vs 48 ~ 9, p - 0.0001), and attained higher peak %PHR (95 ~ 14 
vs 86 ~ 11. p ~ 0.0001) ~n a shorter stress tcme (13 ± 3 vs 15 ± 3 min. p - 
0.0001). with less atropine use (15% vs 32%. p -- 0.0041 ) and lower peak Db 
dose (20 ± 9 vs 26 ± 12 rag, p - 0.0001 ). Target HR was achieved in 86% P~ 
with and without AF. with comparable incidence of eCtopics and dose limiting 
side effects. Ischemia (tSC: new or worse wall m,Jtiun) was detected in 13% 
AF vs 18% SR (p = NS). Of 115 pts with AF, t08 were available tot t;u tor -6  
m (mean 20 months): 28 pts died. 13 of cardiac causes. Of these 13. only 2 
